ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,407 | -20.1% | 11,640 | +13.4% | 0.00% | – |
| Q2 2023 | $14,273 | -96.1% | 10,268 | -41.0% | 0.00% | – |
| Q2 2021 | $368,000 | -27.4% | 17,390 | -3.8% | 0.00% | -100.0% |
| Q1 2021 | $507,000 | +3.3% | 18,079 | -4.3% | 0.00% | 0.0% |
| Q4 2020 | $491,000 | -33.4% | 18,895 | -4.7% | 0.00% | 0.0% |
| Q3 2020 | $737,000 | -47.0% | 19,824 | -26.9% | 0.00% | -50.0% |
| Q2 2020 | $1,391,000 | +63.6% | 27,114 | +0.5% | 0.00% | +100.0% |
| Q1 2020 | $850,000 | -4.4% | 26,976 | +80.9% | 0.00% | 0.0% |
| Q4 2019 | $889,000 | +70.6% | 14,909 | +5.0% | 0.00% | 0.0% |
| Q3 2019 | $521,000 | +3907.7% | 14,202 | +5102.2% | 0.00% | – |
| Q2 2019 | $13,000 | +18.2% | 273 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | -15.4% | 273 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -7.1% | 273 | -16.0% | 0.00% | – |
| Q3 2018 | $14,000 | +27.3% | 325 | +15.2% | 0.00% | – |
| Q2 2018 | $11,000 | -45.0% | 282 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | +5.3% | 282 | 0.0% | 0.00% | – |
| Q4 2017 | $19,000 | +35.7% | 282 | 0.0% | 0.00% | – |
| Q3 2017 | $14,000 | +7.7% | 282 | 0.0% | 0.00% | – |
| Q2 2017 | $13,000 | +30.0% | 282 | +1.8% | 0.00% | – |
| Q1 2017 | $10,000 | +233.3% | 277 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 277 | +6.5% | 0.00% | – |
| Q3 2016 | $4,000 | +100.0% | 260 | +7.4% | 0.00% | – |
| Q2 2016 | $2,000 | -50.0% | 242 | +2.1% | 0.00% | – |
| Q1 2016 | $4,000 | -20.0% | 237 | +8.2% | 0.00% | – |
| Q4 2015 | $5,000 | 0.0% | 219 | +5.8% | 0.00% | – |
| Q3 2015 | $5,000 | -66.7% | 207 | +10.7% | 0.00% | – |
| Q2 2015 | $15,000 | – | 187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |